+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
From
From
From
From
From
From
From
From
From
From
Human Growth Hormone Drugs - Global Strategic Business Report - Product Thumbnail Image

Human Growth Hormone Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 335 Pages
  • Global
From
Critical Care Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Critical Care Therapeutics - Global Strategic Business Report

  • Report
  • November 2025
  • 280 Pages
  • Global
From
Pharmerging - Global Strategic Business Report - Product Thumbnail Image

Pharmerging - Global Strategic Business Report

  • Report
  • November 2025
  • 184 Pages
  • Global
From
Prescription Drugs - Global Strategic Business Report - Product Thumbnail Image

Prescription Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 269 Pages
  • Global
From
From
From
Lyophilisation in Pharmaceutical Market Report 2023-2033 - Product Thumbnail Image

Lyophilisation in Pharmaceutical Market Report 2023-2033

  • Report
  • November 2022
  • 260 Pages
  • Global
From
Progesterone - Global Strategic Business Report - Product Thumbnail Image

Progesterone - Global Strategic Business Report

  • Report
  • November 2025
  • 383 Pages
  • Global
From
Loading Indicator